Is HVL Pharma UK Limited FDA approved?

HVL Pharma UK Limited holds 1 FDA-registered establishment in the United Kingdom. Registration puts a site on the FDA's register and open to inspection; it is not an approval of the company. Approvals attach to individual drug applications.

Where are HVL Pharma UK Limited's drugs manufactured?

The FDA register lists Haverhill. Registered operations: analytical testing, active ingredient (API) manufacture, labelling, packaging, relabelling, repackaging.

HVL Pharma UK Limited

Data as of 24 Sept 2026 · How to read this entry

Request a quote Claim this profile

Registered sites: 1
Active NDC listings: 0
Live patents: 0
Countries: 1
Base: United Kingdom

Authorisation

Registered operations

Analytical testing1Active ingredient (API) manufacture1Labelling1Packaging1Relabelling1Repackaging1

Sites

Registered establishments

Establishment	Address	Registered for	FEI / DUNS
HVL Pharma UK Limited	37 Hollands Road, Haverhill, Suffolk CB9 8PU, United Kingdom (GBR)	Analytical testing, Active ingredient (API) manufacture, Labelling, Packaging, Relabelling, Repackaging	3002807062229522842

Compare

Comparable companies in United Kingdom

PENN PHARMACEUTICALS LIMITED1 site · 24 NDC
BTG International Inc1 site · 10 NDC
Minteq U K LTD1 site · 7 NDC
Bespak HC Limited1 site · 5 NDC
Nicobrand Limited1 site · 5 NDC
Rosemont Pharmaceuticals Limited1 site · 5 NDC
Bio Products Laboratory Ltd1 site · 4 NDC
Macfarlan Smith Limited1 site · 4 NDC
Basildon Chemical Co., Ltd.1 site · 3 NDC
Autolus Inc.1 site · 1 NDC

Enquiry

Common questions

Is HVL Pharma UK Limited FDA approved?: HVL Pharma UK Limited holds 1 FDA-registered establishment in the United Kingdom. Registration puts a site on the FDA's register and open to inspection; it is not an approval of the company. Approvals attach to individual drug applications.
Where are HVL Pharma UK Limited's drugs manufactured?: The FDA register lists Haverhill. Registered operations: analytical testing, active ingredient (API) manufacture, labelling, packaging, relabelling, repackaging.

Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.